Stryker (LTS:0R2S) Moat Score: 8/10 (As of Jul. 08, 2026)


LTS:0R2S Stryker Corp LTS:0R2S
89 GF Score
Price $328.34
GF Value $408.81
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Stryker Moat Score?

Stryker LTS:0R2S +0.45% 89 Moat Score is 8 as of Jul. 08, 2026. GuruFocus rates LTS:0R2S with a GF Score™ of 89/100 and a GF Value™ of $408.81 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 844 Medical Devices & Instruments companies, Stryker ranks better than 99.64% on this metric.

Stryker has the Moat Score of 8, which implies that the company might have Wide Moat - Clear and robust wide moat.

Stryker has Wide Moat: Stryker Corp possesses a robust wide moat due to its strong brand, extensive patent portfolio, and significant customer switching costs in the medical device industry. Its superior distribution network and consistent innovation further solidify its durable competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Stryker might have Wide Moat - Clear and robust wide moat.

Stryker  (LTS:0R2S) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Stryker Moat Score Related Terms

LTS:0R2S vs MDT, ABT, BSX: Moat Score Comparison

For the Medical Devices subindustry, Stryker's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stryker Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Moat Score distribution charts can be found below:

* The bar in red indicates where Stryker's Moat Score falls into.


LTS:0R2S
89GF Score
Stryker Corp LTS:0R2S
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 8 mean?
Stryker (LTS:0R2S) has a Moat Score of 8 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Stryker ranks #3 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 0.40000000000001%.
Is Stryker's Moat Score too high?
Stryker's current Moat Score is 8. Based on the distribution chart, Stryker ranks #3 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stryker has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's Moat Score compare to MDT and ABT?
According to the Medical Devices & Instruments industry distribution chart, Stryker ranks #3 out of 844 companies for Moat Score. This places Stryker in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Stryker's current Moat Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Modestly Undervalued. The stock's GF Value™ is $408.81, compared to a current price of $328.34 — trading 19.7% below its estimated fair value. The current Moat Score is 8. Stryker's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current Moat Score is 8 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stryker (LTS:0R2S) Overvalued in 2026?

Based on GuruFocus' analysis, Stryker stock appears to be undervalued. The current stock price of $328.34 is trading 19.7% below its estimated GF Value™ of $408.81. GuruFocus considers Stryker to be Modestly Undervalued.

Key valuation signals for LTS:0R2S:

  • Moat Score: 8
  • GF Value™: $408.81 vs. price of $328.34 (19.7% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stryker Business Description

Address 1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
89GF Score

Get the complete analysis for LTS:0R2S

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$328.34
Price
$408.81
GF Value